Urolithiasis: From pathogenesis to management (part two)
Guohua Zeng*(),Wei Zhu,Ru Huang
Department of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China Guangdong Key Laboratory of Urology, Guangzhou, China
. [J]. Asian Journal of Urology, 2024, 11(2): 137-138.
Guohua Zeng, Wei Zhu, Ru Huang. Urolithiasis: From pathogenesis to management (part two). Asian Journal of Urology, 2024, 11(2): 137-138.
Zeng G, Mai Z, Xia S, Wang Z, Zhang K, Wang L, et al. Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int 2017; 120:109e16.
doi: 10.1111/bju.13828
pmid: 28236332
[2]
Osther PJS. Risks of flexible ureterorenoscopy: pathophysiology and prevention. Urolithiasis 2018; 46:59e67.
doi: 10.1007/s00240-017-1018-6
pmid: 29151117
[3]
Zeng G, Zhong W, Chaussy CG, Tiselius HG, Xu C, Turney B, et al. International Alliance of Urolithiasis guideline on shockwave lithotripsy. Eur Urol Focus 2023; 9:513e23.
[4]
Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: an update on current pharmacological management and future directions. Expet Opin Pharmacother 2013; 14:435e47.
Zeng G, Traxer O, Zhong W, Osther P, Pearle MS, Preminger GM, et al. International Alliance of Urolithiasis guideline on retrograde intrarenal surgery. BJU Int 2023; 131:153e64.
doi: 10.1111/bju.v131.2
[9]
Zeng G, Zhong W, Mazzon G, Choong S, Pearle M, Agrawal M, et al. International Alliance of Urolithiasis (IAU) guideline on percutaneous nephrolithotomy. Minerva Urol Nephrol 2022; 74: 653e68.
doi: 10.23736/S2724-6051.22.04752-8
pmid: 35099162